Skip to content

Clinical trials

Completed Prostatic Hyperplasia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Status: Completed Country / region: France Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20072
20081
20094
20105
20112
20123
20132
20143
20151
20163
20172
20181
20202
20211
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris5
GlaxoSmithKline5
Eli Lilly and Company3
Pierre Fabre Medicament3
Allergan2
Astellas Pharma Europe B.V.2
Centre Hospitalier Universitaire de Nice2
AEterna Zentaris1
Assistance Publique Hopitaux De Marseille1
Astellas Pharma Global Development, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia40
Lower Urinary Tract Symptoms8
Prostatic Neoplasms3
Adenoma1
Erectile Dysfunction1
Inflammation1
Urinary Bladder Neoplasms1
Urinary Bladder, Overactive1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.